Ernest Depuey, MD
Nuclear Medicine · New York, NYNPI 1457344459
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,475 of the $23,658 with a category attached, or 90.8%. Avid Radiopharmaceuticals, Inc. accounts for 99.6% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $21,475 and has fallen 95.4% since, to $981 in 2024. Among nuclear medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $1971.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avid Radiopharmaceuticals, Inc.$24K
- Pfizer$101
Across 3 payments — averaging $28,117 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avid Radiopharmaceuticals, Inc.$84K
What the payments were for
- Consulting fees$21,47591%
- Travel & lodging$1,9338%
- Food & beverage$2501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avid Radiopharmaceuticals, Inc. | 11 | $23,556 |
| Pfizer | 1 | $101 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYNDAMAX$101
How this compares
$23,658 in reported general payments places this provider in the 95th percentile of 84 nuclear medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in New York
- Chaitanya DivgiNew York$2.2M
- Steven LarsonNew York$83K
- Chun KimNew York$22K
- Sean WhalenNew York$22K
- Nasrin GhesaniNew York$10K
- Bilal OmeryNew York$7K
- Mikhail DoubrovinNew York$3K
- Sampanna RayamajhiNew York$2K
- Vetri Sudar JayaprakasamNew York$1K
- Heiko SchoderNew York$889
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.